Form 4: Sabra Health Care REIT Director Jeffrey Malehorn Receives Restricted Stock Unit Grant

Sentiment:

Insider Transaction Report


Sabra Health Care REIT, Inc. Director Jeffrey A. Malehorn was granted 8,178 restricted stock units, increasing his total beneficial ownership to 104,817 shares.

Summary

  • Jeffrey A. Malehorn, a Director of Sabra Health Care REIT, Inc. (SBRA), acquired 8,178 shares of common stock on June 12, 2025.
  • This acquisition was a grant of restricted stock units (RSUs) under the Issuer's 2009 Performance Incentive Plan, with a transaction price of $0 per unit.
  • The RSUs will vest in equal monthly installments starting July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.
  • Following this transaction, Mr. Malehorn's total beneficial ownership in Sabra Health Care REIT, Inc. stands at 104,817 shares.
  • This total includes the newly granted 8,178 unvested stock units and 43,619 stock units that have vested but whose payment has been deferred.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a standard practice that aligns the interests of management with shareholders, as the value of the compensation is tied to the company's stock performance. This is generally viewed positively for corporate governance and long-term value creation.

Positives

  • The grant of restricted stock units to Director Jeffrey A. Malehorn aligns his interests with those of the shareholders, as his compensation is tied to the company's future performance.
  • The transaction demonstrates continued commitment of a key director to the company's long-term success.

Future Outlook

Not applicable for this document type, as it details an individual insider transaction rather than company-wide forward-looking statements.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitors. It is a standard disclosure for executive compensation in the REIT sector.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation StructureThe grant was made under the Issuer's 2009 Performance Incentive Plan, indicating an existing framework for equity compensation.06/12/2025Reinforces alignment of director's interests with shareholder value through equity-based incentives.

Related Party Transactions

  • The transaction involves a grant of equity to a director, which is a common form of related party compensation, but no unusual or specific related party transactions beyond this compensation are detailed.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director helps align the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.

Next Steps

  • The restricted stock units will vest in equal monthly installments beginning July 12, 2025, and ending on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.

Key Dates

DateDescription
06/12/2025Date of earliest transaction (grant of restricted stock units).
06/13/2025Signature date of the reporting person's attorney-in-fact.
07/12/2025Start date for equal monthly vesting installments of the restricted stock units.
06/12/2026End date for vesting installments, or earlier if the next annual stockholders' meeting occurs before this date.

Keywords

Sabra Health Care REIT, SBRA, Jeffrey A. Malehorn, Restricted Stock Units, RSU Grant, Insider Transaction, SEC Form 4, Beneficial Ownership, Director Compensation, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.